Moderna is testing a norovirus vaccine in a phase three trial. Results could be available as soon as this year.
Norovirus cases are significantly increasing in the US and Canada. Moderna is developing an mRNA-based vaccine, currently in Phase 3 clinical trials, with the potential to be the first approved ...
Be it from tap water on a vacation, some dodgy chicken, or something the kids have brought home from school, we've almost all ...
16don MSN
Lehigh Valley’s health networks are seeing abnormally high cases of the stomach bug that’s taking a large number of people out of action and leaving them stuck in the bathroom.
Pharmaceutical company Moderna has launched a large-scale Phase III trial that will test out a vaccine against norovirus, a frequent and sometimes dangerous source of food poisoning. Moderna’s ...
2don MSN
Up to 21 million people contract norovirus each year in the U.S. alone, the CDC says.
There are currently three vaccine candidates moving through the clinical pipeline in human trials right now, and the furthest along is Moderna, which has developed a norovirus vaccine with the ...
Moderna’s mRNA-1403 is a messenger RNA-based trivalent vaccine candidate designed to protect against multiple norovirus genotypes. Moderna provided an update on the status of its trial ...
As norovirus cases increase across the U.S., Moderna is conducting a phase 3 trial with 25,000 participants to test its experimental vaccine, CNBC reported. The vaccine manufacturer is recruiting ...
Yousif Capital Management LLC lifted its stake in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 3.9% during the ...
Janney Montgomery Scott LLC lowered its holdings in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 21.0% in the fourth quarter, ...
BRITS are being urged to stay at home and mask up when venturing outside after a “worrying” surge in norovirus cases. While ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results